Hurt an Organ, Help a Disease?
 By Jennifer Couzin
 ScienceNOW Daily News
 24 January 2008
 
 Researchers report that by injuring an animal's pancreas, they have 
 found a population of cells that naturally become insulin-producers. 
 It's not clear whether the find will impact diabetes patients, but 
 researchers are intrigued by the discovery and what it might reveal 
 about the transformative ability of pancreatic cells.
 In people with diabetes, insulin-producing cells in the pancreas, 
 called beta cells, have been destroyed or may behave sluggishly. This 
 leaves the body unable to regulate its blood sugar. Coaxing the 
 pancreas to make new beta cells is one of the great goals of diabetes 
 research. Scientists debated for years whether the pancreas holds 
 stem cells that could replenish beta cells, but in 2004, biologists 
 led by Douglas Melton at Harvard looked for these stem cells in the 
 pancreas of mice and failed to find them. His team instead reported 
 that existing beta cells could multiply to form new ones (ScienceNOW, 
 5 May 2004). 
 
 Harry Heimberg of Vrije Universiteit in Brussels, Belgium, wondered 
 whether there were additional sources of new beta cells. Earlier 
 experiments in rats had found that clamping a pancreatic duct and 
 stopping digestive enzymes from entering the small intestine roughly 
 doubles the mass of beta cells in the pancreas. But which cells in 
 the pancreas were generating these extra beta cells? 
 
 Heimberg and his colleagues caused the same severe injury in mice. 
 Then they searched for pancreatic cells that might somehow turn into 
 beta cells. To do this, they focused on the genetic marker neurogenin 
 3, which appears in cells slated to become beta cells when they're 
 just beginning to develop in an embryo. Within 3 days of injury, the 
 scientists found cells with this gene. Furthermore, preventing the 
 gene's expression reduced beta-cell proliferation, the group reports 
 in the 25 January issue of Cell. When these neurogenin 3 cells were 
 taken from an adult mouse and injected into a pancreas removed from a 
 mouse embryo, they developed into beta cells and produced insulin, 
 suggesting that the cells were developing into new beta cells in the 
 injured animal. Further studies found that the neurogenin 3 cells 
 weren't making insulin before the injury. That means beta cells 
 hadn't bolstered the beta-cell supply by themselves, as Melton had 
 shown was possible in normal animals. 
 
 Many questions remain. Where do the cells come from, for example? The 
 cells sit along the ducts of the organ, so they could originate as 
 mature ductal cells that revert to an embryonic state after the 
 injury and then become beta cells. Or, says Heimberg, they could be 
 progenitor cells, which unlike stem cells cannot self-replenish. 
 Other big questions are whether the neurogenin 3 cells can be coaxed 
 to come forward in the normal human pancreas without damaging the 
 organ, and whether they can be turned into insulin producers. 
 
 Melton suspects the cells began as mature pancreatic cells, likely 
 from the ducts, as they don't have many characteristics of stem 
 cells. The study, he says, shows that there's another mechanism to 
 keep beta cells coming, which might offer a new cell source to 
 consider in the hunt for ways to replenish beta cells. 
 
 http://sciencenow.
 
 Elusive Pancreas-Healing Cells Discovered
 Mouse finding hints that stemlike cells may yet be found in human 
 pancreas
 By JR Minkel 
 
 PROGENITOR POWER: Injections of newly discovered mouse pancreatic 
 cells (green) into an embryonic mouse pancreas engineered to function 
 improperly restored its hormone-secreting ability.
 Courtesy of Harry Heimberg and Xiaobo Xu
 Don't call them stem cells just yet, but researchers say they have 
 discovered a rare and long-sought class of cell in adult mice that is 
 responsible for patching up an injured pancreas. If equivalent cells 
 were found in the human pancreas, the hope is that they would point 
 the way to therapies for growing new insulin-secreting beta islet 
 cells, which cause diabetes when they break down.
 
 "That's the far away dream, but the data we find in mice gives us the 
 hope this kind of reasoning makes sense," says biologist Harry 
 Heimberg of Vrije University Brussels in Belgium, who the led the 
 research, published in the journal Cell.
 
 Unlike stem cells, the newly discovered cells, referred to as 
 progenitors, do not reproduce repeatedly in the lab. But according to 
 the study, they are capable of differentiating into all cell types of 
 the islets of Langerhans, pancreatic structures that include beta 
 cells and cells that secrete hormones such as glucagon and 
 somatostatin. Heimberg and his co-workers first injured the islets of 
 adult mice by clamping shut the ducts that carry digestive enzymes 
 out of the pancreas, causing a destructive backup.
 
 The injured pancreases, forced to repair themselves, soon swelled 
 with double the normal number of beta cells. The researchers note 
 that the only previously known source of new beta cells in adult mice 
 was the slow cell division of preexisting beta cells. Seeking fresh 
 sources, they looked for cells that express the gene neurogenin 3, a 
 potential sign of cell differentiation because it is the first gene 
 to only switch on in pancreatic islets during embryonic development. 
 The team found an estimated 5,000 such cells, some of which were 
 isolated and tested for their ability to restore beta cell activity.
 
 The researchers did this by injecting the cells into embryonic 
 pancreatic tissue taken from mice engineered to lack neurogenin 3. 
 The embryonic pancreas was incapable of secreting insulin and other 
 hormones by itself. But the extracted tissue began producing insulin, 
 glucagon and other hormones after the newly identified cells were 
 added, indicating that they were indeed progenitors capable of 
 differentiating into all the islet cell types, including beta cells.
 
 The source of these progenitors, however, remains a mystery. "It's 
 necessary now to look for the precursors of these progenitors,
 Heimberg says, which may be more like true stem cells.
 
 http://www.sciam.
 ---
 Elusive pancreatic progenitor cells found in mice
 January 25, 2008 --New York, NY-- Researchers in Belgium have 
 significantly advanced the discovery of a pancreatic progenitor cell 
 with the capacity to generate new insulin-producing beta cells. If 
 the finding made in mice holds for humans, the newfound progenitor 
 cells may represent "an obvious target for therapeutic regeneration 
 of beta cells in diabetes," the researchers report in the Jan. 25 
 issue of the research journal Cell, a publication of Cell Press. In 
 people with type 1 diabetes, blood sugar rises due to a loss of the 
 insulin-producing pancreatic beta cells. Insulin is a hormone that 
 helps the body use glucose for energy. 
 
 "One of the most interesting characteristics of these [adult] 
 progenitor cells is that they are almost indistinguishable from 
 embryonic progenitor cells," said Harry Heimberg at the Juvenile 
 Diabetes Research Foundation Center at Vrije Universiteit Brussel in 
 Belgium and the Beta Cell Biology Consortium. "In terms of their 
 structure and gene expression, there are no major differences. They 
 look and behave just like embryonic beta cell progenitors.
 
 "We at JDRF believe that this new research provides novel insights 
 that may provide therapeutic potential to regenerate beta cells in 
 type 1 diabetes," said Patricia Kilian, Regeneration Program Director 
 at JDRF.
 
 Previous studies have suggested the existence of a beta cell 
 progenitor in the pancreas after birth, but the identification and 
 characterization of the progenitor cell has not been fully achieved. 
 Other studies showing that replication of adult beta cells can 
 account for beta cell turnover and expansion of beta cells under 
 normal physiologic conditions and called into question the role or 
 existence of a progenitor cell in regeneration. "Most people gave up 
 looking because the cells are so few and so hard to activate," added 
 Heimberg.
 
 In the new study, Heimberg's team tied off a duct that drains 
 digestive enzymes from the pancreas, a manipulation that led to a 
 doubling of beta cell mass in the injured part of the pancreas within 
 two weeks. The animals' pancreases also began producing more insulin, 
 evidence that the new beta cells were fully functional. Using a 
 genetic labeling technique, the researchers found that the new beta 
 cells were derived from precursor cells that expressed a gene 
 expressed in embryonic progenitor cells called Neurogenin 3 (Ngn3) 
 and that production of the new beta cells depended on activity of 
 this gene. He suspects the regenerative process is sparked by an 
 inflammatory response in the enzyme-flooded pancreas. 
 
 "The most important challenge now is to extrapolate our findings to 
 patients with diabetes," Heimberg reported. Although he cautioned 
 that any potential diabetes treatment remains in the future, he 
 said "our findings reveal the significance of investigating the 
 feasibility of both isolating facultative beta cell progenitors and 
 newly formed beta cells from human pancreas in order to expand and 
 differentiate them in vitro and transplant them in diabetic patients 
 and also composing a mix of factors able to activate beta cell 
 progenitors to expand and differentiate in situ in patients with an 
 absolute or relative deficiency in insulin." 
 
 ###
 About JDRF 
 
 JDRF (www.jdrf.org) was founded in 1970 by the parents of children 
 with juvenile diabetes  a disease that strikes children suddenly, 
 makes them insulin dependent for life, and carries the constant 
 threat of devastating complications. Since inception, JDRF has 
 provided more than $800 million to diabetes research worldwide. More 
 than 80 percent of JDRF' expenditures directly support research and 
 education about research. JDRF's mission is constant: to find a cure 
 for diabetes and its complications through the support of research.
 
 Public release date: 25-Jan-2008
 Contact: Susan Sherman
 ssherman@jdrf.
 212-479-7510
 Juvenile Diabetes Research Foundation International 
 
 http://www.eurekale
 
 
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Earn your degree in as few as 2 years - Advance your career with an AS, BS, MS degree - College-Finder.net.
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___




